0 likes | 11 Views
Thalassemia Treatment Market, By Type (Alpha-Thalassemia and Beta-Thalassemia), By Treatment (Blood Transfusions, Iron Chelation Therapy, Folic Acid Supplements, Gene Therapy and Bone Marrow Transplant), By End-User (Hospitals & Clinics, Diagnostic Laboratories and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030<br>
E N D
Global Thalassemia Treatment Market : Industry, Size, Share, Growth, Trends and Forecast, 2019–2029 February 2021 Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Report Snippet Chapter 1 : Table of Contents Chapter 2: Market Purview Chapter 3: Market Dynamics Chapter 4: Global Thalassemia Treatment Market , By Type Chapter 6: Global Thalassemia Treatment Market , By End User Chapter 5: Global Thalassemia Treatment Market , By Treatment Chapter 7: Global Thalassemia Treatment Market , By Region Chapter 8: Company Profiles Investment Outlook Future of the Market Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Table of Contents Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Table of Content Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Table of Content Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Table of Content Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Table of Content Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Table of Content Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Table of Content Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Table of Content Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Table of Content Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Table of Content Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Table of Content Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Table of Content Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Table of Content Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Table of Content Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
About Us Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
About Us Who we are: Prophecy is a specialized market research, analytics, marketing and business strategy, and service offerings company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible Service Offerings to overcome them and transform their business. Prophecy’s expertize area covers types, applications, latest trends, developments, market growth factors, and challenges along with market forecast in various business areas such as Healthcare, Pharmaceutical, Biotechnology, Information Technology (IT), Hospitals, Small and Ownership Model-sized enterprises (SMEs), Others, Agriculture, Food and Beverage, Energy, and Oil and Gas. We also offer various other Adaptive Pants such as, data mining, information management, and revenue enhancement suggestions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never return down from any challenge. At prophecy we cater to industries, individuals, and organizations across the globe and deliver our offerings in the shortest possible turnaround time. Our well defined approach ensures our clients will receive unique competitive advantage, and secure and long lasting results. “WE BELIEVE IN LONG–TERM BUSINESS RELATIONS FOR GROWTH AND SUCCESS” Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
About Us More than 100+ Clients worldwide including various Fortune 500Companies A rich repository of syndicated reports across 8Industries Pioneer in adopting best research practices to ensure deeper insights DedicatedAnalyst Working 2+ years of industry experience in delivering valuable research Insights at Global, Regional and Country Level Top leadership having more than 50 man years of experience across varied industries Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Research Methodology 2.This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario. 3.This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and Applications of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years. • 4. This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity. 1. This step involves identification of several primary and secondary data research sources, including Prophecy internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and Pharmaceuticals and non Pharmaceuticals agencies websites. This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Research Objective To analyze several micro-market indicators considering growth factors, market prospects, and strategic market contribution To examine competitive scenarios such as collaborations, mergers and acquisitions, R&D activities, and advanced developments Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Research Process Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Research Methodology Global Market Size Market/Revenue share split by each market segment such as By Type Fracturing Fluids/Fracturing Fluids sector/end user Market/Revenue share of each key player in each Type segment Market/Revenue share of each key player in the global market Market/Revenue share split by each region and country in the global market • Top-down Approach – • Market size and analysis validation through primary and secondary research participants and key opinion leaders. • Primary Sources: • Demand Side Key Opinion Leaders • Supply Side Key Opinion Leaders • Secondary Sources: • Annual Reports • Financial Reports and Presentations • Press Releases • Research Journals • Paid Data Sources • Bottom-up Approach – • Collection of market related data and information from primary and secondary sources, and data analysis. • Primary Sources: • Demand Side Key Opinion Leaders • Supply Side Key Opinion Leaders • Secondary Sources: • Annual Reports • Financial Reports and Presentations • Press Releases • Research Journals • Paid Data Sources Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Research Methodology Definition and Scope – Prophecy Market Insightsprovide the market definition to understand the target Type/service and provide the market scope to understand the report coverage after thoroughly understanding of target market and market specific requirements. Primary Research – We formulates a detailed discussion guide to perform primary research. In primary research collection of data is performed through telephonic interview, E-mail questionnaire’s, and in-depth discussion with industry experts, manufacturers, suppliers, and distributors. The primary research participant includes but not limited to CEO’s, Managers, Directors, VP’s, Suppliers, CSO’s, and etc. Secondary Research – Our research analyst performs in-depth secondary research and extensive data mining to collect market related information through various authentic data sources such as Annual Reports, Trade Publications, Magazines, Research Publications, Company Press Release, and some paid data sources. In-house Data Analysis – After extensive data mining, we perform in-house market analysis by using various data tools, statistical methods, and data analysis tools to arrive on a conclusion and reduce the margin of error. We provide our overviews and market forecast for the target market after thoroughly understanding and analyzing of collected data, historic market trends, and research outputs. Report Delivery – Prophecy Market Insights provide report in required electronic format (preferably in PDF format), as PDF format is easy to read and present. Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Preface Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Scope & Coverage The report considers 2019 as the base year. All calculations involving quantitative data are based on 2019. The values represented in the report are actual values for 2019, whereas, the values are estimated for the period 2020−2029. Base Year Estimated Year Forecast Years Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Market Segmentation Global Thalassemia Treatment Market By Type By Region By Treatment By End User • North America • Europe • Asia Pacific • Latin America • Middle East & Africa • Alpha-thalassemia • Beta-thalassemia • Hospitals & Clinics • Diagnostic Laboratories • Others • Blood Transfusions • IronChelationTherapy • Folic Acid Supplements • Gene Therapy • BoneMarrow Transplant Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Currency Conversion Currency Conversion 2013-2018 The standard currency used throughout the report is USD ($). However, in the case of other currencies, the annual average currency rate (January 1 to December 31) is used for conversion. These conversion rates are rounded to the nearest decimal place. The chart below represents the standard conversion rates used in the report. Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Chapter 02 Market Purview Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Executive Summary (1/9) Overview • The Global Thalassemia Treatment Market accounted for US$ 2.3 billion in 2020 and is estimated to be US$ 14.7 billion by 2030 and is anticipated to register a CAGR of 10.40%. Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Executive Summary (3/9) Table 2.1: Global Thalassemia Treatment Market Overview Source: Prophecy Market Insights To be Continued … Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Executive Summary (4/9) Table 2.2: Global Thalassemia Treatment Market Overview Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Executive Summary (5/9) Description Figure 2.1: Global Thalassemia Treatment Market Value Share (%), By Type – 2020 (E) • The Global Thalassemia Treatment Market accounted for US$ 2.3 billion in 2020 and is estimated to be US$ 14.7 billion by 2030 and is anticipated to register a CAGR of 10.40%. Thalassemia is an inherited blood disorder characterized by decreased hemoglobin production. Symptoms range from mild to severe anemia which can result in tiredness and pale skin with bone problems, an enlarged spleen, yellowish skin, and dark urine. There are two main types, alpha thalassemia and beta thalassemia. Analysis Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Executive Summary (6/9) Figure 2.2: Global Portable Figure 2.3: Global Thalassemia Treatment Market Value Share (%), By End User - 2020(E) Figure 2.2: Global Thalassemia Treatment Market Value Share (%), By Treatment – 2020 (E) Figure 2.4: Global Thalassemia Treatment Market Value Share (%), By Region – 2019 (E Analysis and Outcome Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Executive Summary (5/9) Description Figure 2.4: Global Thalassemia Treatment Market Value Share (%), By Region – 2020 (E) • The EU5 countries held the largest share among the seven major markets, with a 38.0% share in 2016, followed by U.S. and Japan. • Introduction of gene therapy for the treatment of thalassemia is expected to boost the market share of the U.S. and EU. • In the rest of the world, the adoption of gene therapy for thalassemia treatment will be slower; however, significant growth is anticipated in the forecast period. • Beta-thalassemia is a common autosomal recessive disorder. It is relatively rare in the U.S. • Approximately one in every 100,000 individuals in the global population shows symptoms of this disease. • The disease is particularity prevalent in the Mediterranean region, Africa, Middle East, Central Asia, the Indian subcontinent, and the Far East. Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Executive Summary Market at Glance (2020) Europe: XX Mn CAGR: XX% North America: XX Mn CAGR: XX% APAC: XX Mn CAGR: XX% Latin America: XX Mn CAGR: XX% MEMA: XX Mn CAGR: XX% Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Chapter 03 Market Dynamics Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Drivers (1/4) Increase in awareness about available treatment options • Large population, increase in awareness about available treatment options, and rise in demand for improved curative gene therapies are some of the major factors expected to drive the market. • Thalassemia is a rare hereditary blood disorder characterized by the production of abnormal hemoglobin, which is responsible for the destruction of red blood cells, leading to anemia. Blood transfusion and iron chelation therapies are the only treatment options available at present. This gives rise to ample opportunities in the market for the development of a universal curative treatment for thalassemia. • According to the Thalassemia International Federation, approximately 7.0% of the global population suffers from diseases and conditions associated with hemoglobin, out of which around 70.0% have sickle cell anemia and the remaining develop thalassemia or other blood disorders. Around 2.1% of the global population is living with various forms of thalassemia. This disorder affects approximately 4.4 in every 10,000 live births worldwide. • The disease is most prevalent in Greece, coastal regions of Turkey, some parts of Italy, major Mediterranean islands such as Cyprus, and South Asian countries such as Maldives and India. In the U.S., thalassemia is considered as an orphan or rare disease, which affects less than 20,000 people. Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Drivers (2/4) Increase in Pharmaceutical R&D Spending Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Drivers (3/4) Value Added Features in Thalassemia Treatments to Propel Global Market • The global thalassemia treatment market is projected to be driven by value added features offered by various thalassemia drug manufacturing companies in order to streamline the day to day work flow and increase revenue. • The thalassemia treatment provides limited range of features and benefits ranging from patient pain heeling remedies to treatment procedures. For instance, very less number of people go for the much beneficial chelation therapy. • These features help physicians and nurses to streamline the chelation therapy required for patients to maintain their daily workflow efficiently and effectively. Key players offering thalassemia treatment are coming up with value added features such as bone marrow transplantation, stem cell regeneration, gene editing methodologies, and effective modality features used for drug manufacturing along with creating a prominent candidate molecule for drugs. • These features can reduce the overall operating cost and improve the overall effectiveness and efficiency of treatment practices. Companies are focusing on the development of combined drug therapy in their system to effectively integrate chelating therapy or other treatment procedure at an affordable cost. • These value added features save time for physicians and help improve thalassemia patient survival performance. Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Drivers (4/4) XXX Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Restraint (1/2) High operation cost of sophisticated clinical and preclinical imaging systems Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Opportunity Development of advanced technologies to tap niche markets Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Challenge xxx Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Trend Trend of R&D among Leading Players to Increase Geographic Presence • In December 2017, Shire plc committed to pay approximately US$ 1,409.9 Mn to contract vendors for administering and executing clinical trials. Other prominent players operating in the global thalassemia treatment include Incyte Corporation, Kiadis Pharma, Gamida Cell, Celgene Corporation, and Bellicum Pharmaceuticals. Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Drivers Drivers and Restraints Impact Analysis D1 • Increase in awareness about available treatment options High • Increase in Pharmaceutical R&D Spending Restraints D2 • Value Added Features in Thalassemia Treatments to Propel Global Market D3 D4 • xxx Impact on Market Growth Rate Likely Growth • High operation cost of sophisticated clinical and preclinical imaging systems R1 • xxx R2 Low Low Impact on Market Value High Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
PORTER’S FIVE FORCES ANALYSIS Analysis Outcome THREAT OF SUBSTITUTES THREAT OF NEW ENTRANTS High Medium COMPETITIVE RIVALRY BARGAINING POWER OF SUPPLIERS High BARGAINING POWER OF BUYERS High High Source: Prophecy Market Insights Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved The Porter’s five forces model studies the five identified competitive forces that shape every industry and market, in order to determine the intensity of the competition, and thus, the profitability and attractiveness of the industry. The objective of the growth strategy is to adapt to these competitive forces in a manner that may improve the position of the organization. This study includes an exhaustive Porter’s five forces framework, incorporating the factors influencing each force, to analyze the market from a microeconomic perspective. In the study, Porter’s five forces are analyzed considering the factors influencing each force and quantifying the factors, through primaries and quantitative analysis. The quantified factors are further mapped out, to derive the impact of each force on competitive dynamics.
PORTER’S Five Forces Analysis Threat of New Entrants Medium 01 Buyer Power High 02 Supplier Power High 03 Threats of Substitutes High 04 Competitive Rivalry High 05 Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Key Highlights 02 04 03 01 Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved
Key Highlights 06 08 05 07 Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved